Searched for: department:Medicine. General Internal Medicine
recentyears:2
school:SOM
Comparative DNA sequencing of 16S rRNA and coagulase gene PCR products for identification and typing of Staphylococcus aureus [Meeting Abstract]
Bost, D. A.; Kreiswirth, B.; Montgomery, S. O.; Smith, D. H.; Shopsin, B.; Anderon, S. B.; Dodge, D. E.
BIOSIS:PREV199799583834
ISSN: 1060-2011
CID: 105021
Younger at last : the new world of vitality medicine
Lamm, Steven; Couzens, Gerald Secor
New York : Simon & Schuster, 1997
Extent: 253 p.; 25cm
ISBN: 0684834383
CID: 865
Physician-assisted suicide: three crucial distinctions
Spritz, N
PMID: 12455517
ISSN: 0199-4646
CID: 74227
The Medical Interview
Chapter by: Lipkin, Mack JR
in: Behavioral medicine in primary care: A practical guide by Feldman, Mitchell D; Christensen, John F. [Eds]
New York, NY : McGraw-Hill, 1997
pp. 1-9
ISBN: 0071383360
CID: 4070
Treatment of grade III acromioclavicular separations. Operative versus nonoperative management
Press J; Zuckerman JD; Gallagher M; Cuomo F
Twenty-six patients with Grade III acromioclavicular joint separations were evaluated to determine the outcomes of nonoperative and operative management. Evaluation consisted of a detailed functional questionnaire, physical examination, and comprehensive isokinetic strength assessment. The patients were divided into two groups: operative (n = 16) and nonoperative (n = 10). Operative management consisted of coracoclavicular stabilization with heavy suture material and with nine of the sixteen patients treatment also consisted of coracoacromial ligament transfer and lateral clavicle resection. Nonoperative management consisted of short-term immobilization with early range of motion and rehabilitation. The two groups were similar in all characteristics except mean age: 30.7 years for the operative group and 49.6 years for the nonoperative group. Follow-up evaluation was performed an average of 32.9 months after either injury (nonoperative group) or surgery. Our results indicated that nonoperative management was superior to operative management with respect to time to return to work (0.8 months vs. 2.6 months), time to return to athletics (3.5 months vs. 6.4 months) and time of immobilization (2.7 weeks vs. 6.2 weeks). However, operative management was superior to nonoperative management in the following parameters: time to attain completely pain-free status, the patient's subjective impression of pain, range of motion, functional limitations, cosmesis, and long-term satisfaction. There were no significant differences between the two groups with respect to shoulder range of motion, manual muscle testing, or neurovascular findings. Isokinetic strength testing of the involved shoulder, expressed as a percentage of the uninvolved shoulder, showed no significant differences in peak torque, total work, or total power between the operative and nonoperative groups. However, comparison of the involved to the uninvolved extremity within each group did reveal a trend toward decreased peak torque, work, and power for abduction in the involved extremity regardless of the treatment used. These findings reached statistical significance only for power at the slower testing speed (60 degrees/sec). There was also a significant decrease in power in the involved extremity for external rotation at the faster speed (120 degrees/sec) in the nonoperative group. Finally, the absolute values for peak torque, work, and power were significantly greater for all motions tested in the operative group as compared to the nonoperative group. This may reflect the difference in age between the two groups. Based upon the patients studied, there are benefits to both nonoperative and operative methods of treatment of Grade III acromioclavicular separations. Recovery of strength did not differ between the two groups and therefore should be viewed as a less important factor in patient selection for operative versus nonoperative management. Careful patient selection should remain an important aspect of treatment for this controversial injury
PMID: 9220095
ISSN: 0018-5647
CID: 56980
English research finds no heart benefits in taking garlic pills // MEDICINE: Two-part study finds that previous research indicating garlic can lower cholesterol and blood fats is flawed, incorrect. [Newspaper Article]
Altman, Lawrence K
The suggestion that garlic has protective effects against heart disease has been challenged by a study in England that found that a powdered form of the clove was no better than a dummy pill in lowering cholesterol and fats in the blood
PROQUEST:22379690
ISSN: 0886-4934
CID: 84540
Researchers refute studies that found garlic good for heart [Newspaper Article]
Altman, Lawrence K
The suggestion that garlic has protective effects against heart disease has been challenged by a study in England that found that a powdered form of the clove was no better than a dummy pill in lowering cholesterol and fats in the blood
PROQUEST:22346268
ISSN: 0839-3222
CID: 84541
Scientists say garlic's benefits may be exaggerated [Newspaper Article]
Altman, Lawrence K
The suggestion that garlic has protective effects against heart disease has been challenged by a study in England that found that a powdered form of the clove was no better than a dummy pill in lowering cholesterol and fats in the blood. Earlier studies had suggested several benefits of 'the stinking bulb' in protecting against heart disease and heart attacks. One is to reduce the level of cholesterol and other lipids, or fats, in the blood. A second is to block the action of platelets, the tiny fragments that help blood clot. A third is to enhance the activity of antioxidants
PROQUEST:17531769
ISSN: n/a
CID: 84542
GARLIC NO HEART HELP, STUDY SAYS [Newspaper Article]
Altman, Lawrence K
PROQUEST:10636914
ISSN: 1055-3053
CID: 84543
Study challenges benefits of garlic [Newspaper Article]
Altman, Lawrence K
PROQUEST:16923402
ISSN: n/a
CID: 84545